Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Prognostic value of high-sensitive cardiac troponin I in asymptomatic chronic hemodialysis patients

Abstract

Introduction

Increased levels of cardiac troponins (cTn) are a hallmark of acute myocardial infarction (AMI), along with symptoms and electrocardiographic (ECG) changes. Stably elevated cTn concentrations are frequently observed in asymptomatic patients with chronic kidney disease (CKD) and/or on hemodialysis (HD); the meaning of this elevation, as assessed by conventional techniques, remains unclear. Aim of our study was to evaluate the clinical significance of cTnI levels in asymptomatic HD patients by employing a newer high-sensitive cTnI (hs-cTnI) assay.

Methods

We enrolled 49 patients undergoing regular HD treatment for more than 3 months; all patients were asymptomatic for chest pain and had no history of acute coronary syndrome in the past 2 months. For every patient we measured hs-cTnI, cTnI and brain natriuretic peptide (BNP) before initiation of one HD session at baseline (T0), after 3 (T1) and 9 months (T2). Demographic, anamnestic, dialytic and echocardiographic characteristics of the examined population were evaluated. We also recorded the number of cardiovascular events from T0 to 12 months after T2.

Results

Fifteen patients were lost to follow-up: 6 died, 2 underwent kidney transplantation, 7 did not match the inclusion criteria later during observation. At T0 (49 patients) we observed 14 hs-cTnI positive patients vs. 4 standard c-TnI positive patients (28,5% vs 8,1%); at T1 (40 patients) 16 vs 3 (26.4% vs 7.5%); at T2 (34 pz) 9 vs 0 (26.4% vs 0%). During the study we recorded 10 cardiovascular events, 8 of which in patients that were hs-cTNI positive, leading to death in 3. Hs-cTnI levels were predictive of cardiovascular events at all times and predictive of cardiovascular mortality at T0 and T1 (p < 0.001). In a multivariate analysis, a history of coronary artery disease (CAD) was an independent variable of high hs-cTnI levels at T0 (p < 0.04) and T1 (p < 0.03).

Conclusions

Our study shows that a novel sensitive assay detects more asymptomatic HD patients compared to previously used methods, being at the same time predictive of cardiovascular mortality and morbidity. The only independent variable of high hs-cTnI concentrations was a positive history of cardiovascular disease, suggesting a possible role of hs-cTnI in identifying a high-risk subset of patients.

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD (2012) Third universal definition of myocardial infarction. J Am Coll Cardiol 60:1581–1598. https://doi.org/10.1016/j.jacc.2012.08.001

  2. 2.

    Wang AY, Lai KN (2008) Use of cardiac biomarkers in end-stage renal disease. J Am Soc Nephrol 19:1643–1652. https://doi.org/10.1681/ASN.2008010012

  3. 3.

    Potter JM, Simpson AJ, Kerrigan J, Southcott E, Salib MM, Koerbin G, Hickman PE (2017) The relationship of plasma creatinine (as eGFR) and high-sensitivity cardiac troponin and NT-proBNP concentrations in a hospital and community outpatient population. Clin Biochem 50:813–815. https://doi.org/10.1016/j.clinbiochem.2017.04.003

  4. 4.

    Keddis MT, El-Zoghby ZM, El Ters M, Rodrigo E, Pellikka PA, Jaffe AS, Cosio FG (2013) Cardiac troponin T before and after kidney transplantation: determinants and implications for post-transplant survival. Am J Transplant 13:406–414. https://doi.org/10.1111/j.1600-6143.2012.04317.x

  5. 5.

    Castini D, Persampieri S, Floreani R, Galassi A, Biondi ML, Carugo S, Cozzolino M (2017) Troponin I levels in asymptomatic hemodialysis patients. Blood Purif 44:236–243. https://doi.org/10.1159/000480225

  6. 6.

    Lippi G, Tessitore N, Montagnana M, Salvagno GL, Lupo A, Guidi GC (2008) Influence of sampling time and ultrafiltration coefficient of the dialysis membrane on cardiac troponin I and T. Arch Pathol Lab Med 132:72–76. https://doi.org/10.1043/1543-2165(2008)132%5b72:IOSTAU%5d2.0.CO;2

  7. 7.

    Diris JH, Hackeng CM, Kooman JP, Pinto YM, Hermens WT, van Dieijen-Visser MP (2004) Impaired renal clearance explains elevated troponin T fragments in hemodialysis patients. Circulation 6(109):23–25. https://doi.org/10.1161/01.CIR.0000109483.45211.8F

  8. 8.

    Mavrakanas TA, Sniderman AD, Barré PE, Vasilevsky M, Alam A (2016) High ultrafiltration rates increase troponin levels in stable hemodialysis patients. Am J Nephrol 43:173–178. https://doi.org/10.1159/000445360

  9. 9.

    Artunc F, Mueller C, Breidthardt T, Twerenbold R, Peter A, Thamer C, Weyrich P, Haering HU, Friedrich B (2012) Sensitive troponins–which suits better for hemodialysis patients? Associated factors and prediction of mortality. PLoS One 7:e47610. https://doi.org/10.1371/journal.pone.0047610

  10. 10.

    Lamb EJ, Kenny C, Abbas NA, John RI, Webb MC, Price CP, Vickery S (2007) Cardiac troponin I concentration is commonly increased in non dialysis patients with CKD: experience with a sensitive assay. Am J Kidney Dis 49:507–516. https://doi.org/10.1053/j.ajkd.2007.01.015

  11. 11.

    Mishra RK, Li Y, DeFilippi C et al (2013) CRIC study investigators. Association of cardiac troponin T with left ventricular structure and function in CKD. Am J Kidney Dis 61:701–709. https://doi.org/10.1053/j.ajkd.2012.11.034

  12. 12.

    Scheven L, de Jong PE, Hillege HL et al (2012) PREVEND study group: high-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rate. Eur Heart J 33:2272–2281. https://doi.org/10.1093/eurheartj/ehs163

  13. 13.

    Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A (2005) Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 112:3088–3096. https://doi.org/10.1161/CIRCULATIONAHA.105.560128

  14. 14.

    Michos ED, Wilson LM, Yeh HC, Berger Z, Suarez-Cuervo C, Stacy SR, Bass EB (2014) Prognostic value of cardiac troponin in patients with chronic kidney disease without suspected acute coronary syndrome: a systematic review and meta-analysis. Ann Intern Med 161:491–501. https://doi.org/10.7326/M14-0743

  15. 15.

    Hassan HC, Howlin K, Jefferys A et al (2014) High-sensitivity troponin as a predictor of cardiac events and mortality in the stable dialysis population. Clin Chem 60:389–398. https://doi.org/10.1373/clinchem.2013.207142

  16. 16.

    McGill D, Talaulikar G, Potter JM, Koerbin G, Hickman PE (2010) Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure. Clin Chim Acta 411:936–939. https://doi.org/10.1016/j.cca.2010.03.004

  17. 17.

    Wolley M, Stewart R, Curry E, Davidson J, White H, Pilmore H (2012) Variation in and prognostic importance of troponin T measured using a high-sensitivity assay in clinically stable haemodialysis patients. Clin Kidney J 6:402–409. https://doi.org/10.1093/ckj/sfs122

  18. 18.

    Antunovic T, Stefanovic A, Gligorovic Barhanovic N et al (2017) Prooxidant-antioxidant balance, hsTnI and hsCRP: mortality prediction in haemodialysis patients, two-year follow-up. Ren Fail 39:491–499. https://doi.org/10.1080/0886022X.2017

  19. 19.

    Mavrakanas TA, Sniderman AD, Barré PE, Alam A (2018) Serial versus single troponin measurements for the prediction of cardiovascular events and mortality in stable chronic haemodialysis patients. Nephrology (Carlton) 23:69–74. https://doi.org/10.1111/nep.12945

  20. 20.

    Sandoval Y, Herzog CA, Love SA et al (2016) Prognostic value of serial changes in high-sensitivity cardiac troponin I and T over 3 months using reference change values in hemodialysis patients. Clin Chem 62:631–638. https://doi.org/10.1373/clinchem.2015.251835

  21. 21.

    Artunc F, Nowak A, Müller C, Peter A, Heyne N, Häring HU, Friedrich B (2014) Mortality prediction using modern peptide biomarkers in hemodialysis patients—a comparative analysis. Kidney Blood Press Res 39:563–572. https://doi.org/10.1159/000368468

  22. 22.

    Apple FS, Collinson PO (2012) Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 58:54–61. https://doi.org/10.1373/clinchem.2011.165795

  23. 23.

    Apple FS (2009) A new season for cardiac troponin assays: it’s time to keep a scorecard. Clin Chem 55:1303–1306. https://doi.org/10.1373/clinchem.2009.128363

  24. 24.

    Kumar N, Michelis MF, DeVita MV, Panagopoulos G, Rosenstock JL (2011) Troponin I levels in asymptomatic patients on haemodialysis using a high-sensitivity assay. Nephrol Dial Transplant 26:665–670. https://doi.org/10.1093/ndt/gfq442

  25. 25.

    Niizuma S, Iwanaga Y, Yahata T, Tamaki Y, Goto Y, Nakahama H, Miyazaki S (2009) Impact of left ventricular end-diastolic wall stress on plasma B-type natriuretic peptide in heart failure with chronic kidney disease and end-stage renal disease. Clin Chem 55:1347–1353. https://doi.org/10.1373/clinchem.2008.121236

  26. 26.

    Ma L, Zhao S (2017) Risk factors for mortality in patients undergoing hemodialysis: a systematic review and meta-analysis. Int J Cardiol 238:151–158. https://doi.org/10.1016/j.ijcard.2017.02.095

  27. 27.

    Gunsolus I, Sandoval Y, Smith SW, Sexter A, Schulz K, Herzog CA, Apple FS (2018) Renal dysfunction influences the diagnostic and prognostic performance of high-sensitivity cardiac troponin I. J Am Soc Nephrol 29:636–643. https://doi.org/10.1681/ASN.2017030341

  28. 28.

    Buiten MS, de Bie MK, Rotmans JI et al (2015) Serum cardiac troponin-I is superior to troponin-T as a marker for left ventricular dysfunction in clinically stable patients with end-stage renal disease. PLoS One 10:e0134245. https://doi.org/10.1371/journal.pone.0134245

  29. 29.

    Ross BA, Wald R, Goldstein MB et al (2017) Relationships between left ventricular structure and function according to cardiac MRI and cardiac biomarkers in end-stage renal disease. Can J Cardiol 33:501–507. https://doi.org/10.1016/j.cjca.2016.11.021

  30. 30.

    Ingec M, Oguz EG, Yildirim T, Ulas T, Horoz M (2014) The effect of hemodialysis on cardiac enzyme levels and echocardiographic parameters. Int J Artif Organs 37:513–520. https://doi.org/10.5301/ijao.5000333

Download references

Funding

The study was entirely supported by institutional funding.

Author information

Correspondence to Paolo Menè.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Research Committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Maresca, B., Manzione, A., Moioli, A. et al. Prognostic value of high-sensitive cardiac troponin I in asymptomatic chronic hemodialysis patients. J Nephrol 33, 129–136 (2020). https://doi.org/10.1007/s40620-019-00610-5

Download citation

Keywords

  • Troponins
  • High sensitive-cTnI
  • Hemodialysis
  • Acute myocardial infarction
  • Coronary artery disease
  • Chronic kidney disease